Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster modelResearch in context

Summary: Background: Pulmonary infection with SARS-CoV-2 stimulates host immune responses and can also result in the progression of dysregulated and critical inflammation. Throughout the pandemic, the management and treatment of COVID-19 has been continuously updated with a range of antiviral drugs...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Michihito Sasaki, Tatsuki Sugi, Shun Iida, Yuichiro Hirata, Shinji Kusakabe, Kei Konishi, Yukari Itakura, Koshiro Tabata, Mai Kishimoto, Hiroko Kobayashi, Takuma Ariizumi, Kittiya Intaruck, Haruaki Nobori, Shinsuke Toba, Akihiko Sato, Keita Matsuno, Junya Yamagishi, Tadaki Suzuki, William W. Hall, Yasuko Orba, Hirofumi Sawa
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2024-01-01
سلاسل:	EBioMedicine
الموضوعات:	SARS-CoV-2 COVID-19 Antiviral therapy Corticosteroid Hamster Delayed treatment
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2352396423005169
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!